|
|
|
|
Metoclopramide use confers an increased risk for the initiation of treatment generally reserved for the management of idiopathic Parkinson's disease.Such polypharmacy may represent the misdiagnosis of Parkinson's disease in patients with drug-induced parkinsonian symptoms,which should be ruled out before starting dopaminergic therapy for this condition. |
|